ES2067945T3 - Derivados de hidroxiurea hipoglicemica. - Google Patents

Derivados de hidroxiurea hipoglicemica.

Info

Publication number
ES2067945T3
ES2067945T3 ES91913290T ES91913290T ES2067945T3 ES 2067945 T3 ES2067945 T3 ES 2067945T3 ES 91913290 T ES91913290 T ES 91913290T ES 91913290 T ES91913290 T ES 91913290T ES 2067945 T3 ES2067945 T3 ES 2067945T3
Authority
ES
Spain
Prior art keywords
hypoglycemic
hydroxyurea
derivatives
hidroxiurea
benzil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913290T
Other languages
English (en)
Inventor
Steven Wayne Goldstein
Ruth Elsbree Mcdermott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2067945T3 publication Critical patent/ES2067945T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

SE PRESENTAN CIERTOS DERIVADOS DE LA 1-(BENZIL O 5BENZOFURANILMETIL)-1-HIDROXIUREA QUE SON UTILES COMO AGENTES HIPOGLICEMICOS E HIPOCOLESTEROLEMICOS.
ES91913290T 1990-08-23 1991-06-26 Derivados de hidroxiurea hipoglicemica. Expired - Lifetime ES2067945T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57274590A 1990-08-23 1990-08-23

Publications (1)

Publication Number Publication Date
ES2067945T3 true ES2067945T3 (es) 1995-04-01

Family

ID=24289181

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913290T Expired - Lifetime ES2067945T3 (es) 1990-08-23 1991-06-26 Derivados de hidroxiurea hipoglicemica.

Country Status (22)

Country Link
US (4) US5334604A (es)
EP (1) EP0544696B1 (es)
JP (1) JPH0678326B2 (es)
KR (1) KR930701420A (es)
AT (1) ATE116971T1 (es)
AU (1) AU645112B2 (es)
CA (1) CA2087437A1 (es)
DE (1) DE69106714T2 (es)
DK (1) DK0544696T3 (es)
ES (1) ES2067945T3 (es)
FI (1) FI930772A0 (es)
GR (1) GR3014913T3 (es)
HU (1) HUT70153A (es)
IE (1) IE64927B1 (es)
IL (2) IL99214A0 (es)
MX (1) MX9100804A (es)
NO (1) NO930615D0 (es)
NZ (1) NZ239514A (es)
PT (1) PT98732A (es)
TW (1) TW200470B (es)
WO (1) WO1992003425A1 (es)
ZA (1) ZA916644B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0544696T3 (da) * 1990-08-23 1995-06-06 Pfizer Hypoglycæmiske hydroxyurinstofderivater
DK0696585T3 (da) * 1993-04-30 1999-08-23 Yamanouchi Pharma Co Ltd Nyt bisoxadiazolidinderivat
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
JP3354258B2 (ja) * 1993-12-03 2002-12-09 富山化学工業株式会社 新規なインドール類またはその塩
ATE179709T1 (de) * 1993-12-27 1999-05-15 Japan Tobacco Inc Isoxazolidindionderivate und deren verwendung
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents
RU2151145C1 (ru) * 1994-04-11 2000-06-20 Санкио Компани Лимитед Промежуточное соединение для получения гетероциклических соединений, обладающих антидиабетической активностью
US5420146A (en) * 1994-05-10 1995-05-30 American Home Products Corporation Di-oxadiazolidine derivatives as antihyperglycemic agents
US5468762A (en) * 1994-05-18 1995-11-21 American Home Products Corporation Azolidinediones as antihyperglycemic agents
US5532256A (en) * 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
CA2159938A1 (en) * 1994-10-07 1996-04-08 Hiroaki Yanagisawa Oxime derivatives, their preparation and their therapeutic use
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CN1077107C (zh) 1996-07-19 2002-01-02 武田药品工业株式会社 杂环化合物、其制备和用途
EE03765B1 (et) 1996-08-19 2002-06-17 Japan Tobacco Inc. Propioonhappe derivaadid ja nende kasutamine
JP2001514663A (ja) * 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
DE19711616A1 (de) 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
CN1168451C (zh) 1997-06-18 2004-09-29 史密丝克莱恩比彻姆有限公司 噻唑烷二酮和磺酰脲组合物在制备治疗糖尿病的药物中的用途
PT1022272E (pt) 1997-10-08 2004-08-31 Sankyo Co Compostos heterociclicos fundidos substituidos
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
CN1130361C (zh) 1998-03-30 2003-12-10 日本烟草产业株式会社 异噁唑烷二酮化合物的制备方法
EP1127054A4 (en) * 1998-10-29 2006-11-02 Bristol Myers Squibb Co INHIBITORS OF IMPDH ENZYME
EA007610B1 (ru) 1998-11-12 2006-12-29 Смитклайн Бичам Плс Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
WO2002046154A1 (fr) * 2000-12-05 2002-06-13 Nippon Chemiphar Co., Ltd. Activateurs $g(d) de recepteur active par un proliferateur du peroxysome
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3437664A (en) * 1966-03-18 1969-04-08 Velsicol Chemical Corp 1,2,4-oxadiazolidines
US3895023A (en) * 1973-02-06 1975-07-15 Du Pont Antiinflammatory 1,2,4-oxadiazolidine-3,5-diones
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4342771A (en) * 1981-01-02 1982-08-03 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4406910A (en) * 1981-06-15 1983-09-27 Shell Oil Company Pesticidal 3-(2,3-dihydro-2-alkylbenzofuran-7-yl)-5-(R-oxy)-1,3,4-oxadiazol-2(3H)-ones
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
US4758263A (en) * 1986-10-27 1988-07-19 Sandoz Ltd. 2-(2,5-difluorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5 diones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
US4895953A (en) * 1987-09-30 1990-01-23 American Home Products Corporation 2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
HU217432B (hu) * 1988-03-08 2000-01-28 Pfizer Inc. Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
DK0544696T3 (da) * 1990-08-23 1995-06-06 Pfizer Hypoglycæmiske hydroxyurinstofderivater
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents

Also Published As

Publication number Publication date
IE912971A1 (en) 1992-02-26
IL99214A0 (en) 1992-07-15
IL113141A0 (en) 1995-06-29
JPH05508654A (ja) 1993-12-02
JPH0678326B2 (ja) 1994-10-05
AU8235391A (en) 1992-03-17
DK0544696T3 (da) 1995-06-06
HUT70153A (en) 1995-09-28
US5334604A (en) 1994-08-02
NO930615L (no) 1993-02-22
US5463070A (en) 1995-10-31
WO1992003425A1 (en) 1992-03-05
FI930772A7 (fi) 1993-02-22
US5763467A (en) 1998-06-09
ATE116971T1 (de) 1995-01-15
US5646168A (en) 1997-07-08
DE69106714D1 (en) 1995-02-23
AU645112B2 (en) 1994-01-06
CA2087437A1 (en) 1992-02-24
HU9300486D0 (en) 1993-05-28
MX9100804A (es) 1992-04-01
FI930772L (fi) 1993-02-22
KR930701420A (ko) 1993-06-11
NO930615D0 (no) 1993-02-22
EP0544696B1 (en) 1995-01-11
IE64927B1 (en) 1995-09-20
DE69106714T2 (de) 1995-05-11
ZA916644B (en) 1993-04-28
TW200470B (es) 1993-02-21
GR3014913T3 (en) 1995-05-31
EP0544696A1 (en) 1993-06-09
FI930772A0 (fi) 1993-02-22
PT98732A (pt) 1992-07-31
NZ239514A (en) 1993-10-26

Similar Documents

Publication Publication Date Title
ES2067945T3 (es) Derivados de hidroxiurea hipoglicemica.
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
ES2124479T3 (es) Composiciones biocidas.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
DE59814072D1 (de) Verwendung von Agonisten des zentralen Cannabinoid-Rezeptors CB1
ES2072452T3 (es) Medios cosmeticos desodorizantes.
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
ES2130803T3 (es) Particulas de celulosa, metodo para su fabricacion y utilizacion de las mismas.
TR199901473T2 (xx) Ha�ere �ld�r�c� 1-arilpirazoller
DE59503178D1 (de) Verwendung von gelformulierungen als beizmittel
PT938308E (pt) Agentes antiparasitarios
ES2130269T3 (es) Oximas sustituidas con piridina, pirrolidina y azepina utiles como agentes contra la aterosclerosis y antihipercolesterolemicos.
DE69523622D1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
ES2165395T3 (es) Oxazolinas y tiazolinas artropodicidas.
TR199701576T1 (xx) N-aril-1,2,4,-triazolin-5-onlar.
ES2054944T3 (es) Bis-(tri-t-alquilfenoxi) difosfaespiroundecanos.
BR9406269A (pt) Disposição de peneira pressurizada
DE59508683D1 (de) Verwendung eines polymermaterials auf basis modifizierter hydrokolloide als hüllmaterial
ES2048793T3 (es) Antibioticos antifungicos.
ES2077891T3 (es) Empleo de oximeter derivados para la biorregulacion de las plantas.
ES2128112T3 (es) Nuevas composiciones herbicidas.
ES2059779T3 (es) Compuestos anti-androgenos.
ES2092520T3 (es) Nuevos inhibidores de alfa-manosidasa y fucosidasa.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 544696

Country of ref document: ES